Search
for
Sort by
Research 451–480 of 1000+
- Polycystic ovary syndrome is associated with atherogenic changes in lipoprotein particle number and size independent of body weight
- Congenital adrenal hyperplasia
- Polycystic ovary syndrome (PCOS) trilogy: a translational and clinical review
- LACK OF EFFECT OF OESTROGENS ON ADRENAL ANDROGEN SECRETION IN CHILDREN AND ADOLESCENTS WITH A COMMENT ON OESTROGENS AND PUBIC HAIR GROWTH
- The diagnosis of nonclassic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, based on serum basal or post-ACTH stimulation 17-hydroxyprogesterone, can lead to false-positive diagnosis
- Identification and characterization of an antisense RNA transcript (gfg) from the human basic fibroblast growth factor gene.
- A population‐based nested case–control study: the use of 5‐alpha‐reductase inhibitors and the increased risk of osteoporosis diagnosis in patients with benign prostate hyperplasia
- Relapse of hirsutism following long‐term successful treatment with oestrogen–progestogen combination
- Evaluation of cardiac risk marker levels in obese and non-obese patients with polycystic ovaries
- High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS)
- 5α‐Reductase inhibitors and prostatic disease
- Clinical Case Seminar: Postmenopausal androgen excess-challenges in diagnostic work-up and management of ovarian thecosis
- Coregulation of Genetic Programs by the Transcription Factors NFIB and STAT5
- Beneficial effect of spironolactone on androgenic alopecia
- Sleep disturbances in women with polycystic ovary syndrome
- Defining hyperandrogenaemia according to the free androgen index in Chinese women: a cross-sectional study
- Hair loss and hyperprolactinemia in women
- Characterization of metabolic changes in the phenotypes of women with polycystic ovary syndrome in a large Mediterranean population from Sicily
- Serum vascular endothelial growth factor B is elevated in women with polycystic ovary syndrome and can be decreased with metformin treatment
- Low-dose (2.5 mg/day) finasteride treatment in hirsutism
- No metabolic impact of surgical normalization of hyperandrogenism in postmenopausal women with ovarian androgen-secreting tumours
- Medium-dose prednisolone pulse therapy in alopecia areata
- miR-761-hepcidin/Gpx4 pathway contribute to unexplained liver dysfunction in polycystic ovary syndrome by regulating liver iron overload and ferroptosis
- Observation of phenotypic variation among Indian women with polycystic ovary syndrome (PCOS) from Delhi and Srinagar
- Age-related differences in the reproductive and metabolic implications of polycystic ovarian syndrome: findings in an obese, United States population
- The pressing need for standardization in epidemiologic studies of PCOS across the globe
- The influence of obesity on Androstenedione to Testosterone ratio in women with polycystic ovary syndrome (PCOS) and hyperandrogenemia
- Approach to androgen excess in women: Clinical and biochemical insights
- Comprehensive clinical management of hirsutism
- The investigation and management of severe hyperandrogenism pre- and postmenopause: Non-tumor disease is strongly associated with metabolic syndrome and typically responds to insulin-sensitization with metformin